Article Information
History
- June 5, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Rachel Conyers1,2,3,*,
- Tayla Stenta1,
- Ben Felmingham1,
- Andrew Somogyi4,
- Carl Kirkpatrick5,
- Andreas Halman1,
- Claire Moore1,2,
- Dhrita Khatri1,
- Elizabeth Williams1,
- Roxanne Dyas1,
- David A. Elliott1,2,6,
- Amanda Gwee2,7,8 and
- Marliese Alexander9,10
- 1Cancer Therapies Group, Murdoch Children’s Research Institute, Parkville, Australia
- 2Department of Paediatrics, The University of Melbourne, Parkville, Australia
- 3Children’s Cancer Centre, The Royal Children’s Hospital, Parkville, Australia
- 4School of Biomedicine, University of Adelaide, Adelaide, Australia
- 5Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Australia
- 6The Novo Nordisk Foundation Centre for Stem Cell Medicine, ReNEW, Melbourne Node, Parkville, Australia
- 7Infectious Disease Department, The Royal Children’s Hospital, Parkville, Australia
- 8Antimicrobials Group, Murdoch Children’s Research Institute, Parkville, Australia
- 9Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
- 10Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
- ↵*Corresponding Author A/Prof Rachel Conyers, Cancer Therapies Group, Stem Cell Medicine, Murdoch Children’s Research Institute, Email: rachel.conyers{at}mcri.edu.au, Phone: 03 9345 5502